Infectious Disease Therapeutics Market Report 2026
Download Free Sample Buy Now
Infectious Disease Therapeutics Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Infectious Disease Therapeutics Market Report 2026

Global Outlook – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Infectious Disease Therapeutics Market Overview

• Infectious Disease Therapeutics market size has reached to $150.6 billion in 2025

• Expected to grow to $200.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%

• Growth Driver: Infectious Diseases On The Upswing A Global Health Concern

• Market Trend: Innovators Strengthen Infectious Disease Defense Through Multispecific Therapeutic Technologies

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Infectious Disease Therapeutics Market?

Infectious disease therapeutics refers to the various treatments and interventions aimed at combating illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites. The goal of infectious disease therapeutics is to either eliminate the infectious agent from the body or to control its replication and spread, thereby alleviating symptoms, preventing complications, and ultimately promoting recovery.

The main types of infectious disease therapeutics are drugs and vaccines. Vaccines are biological preparations that stimulate the immune system to recognize and fight specific infectious agents. The various diseases include tuberculosis, HIV/aids, influenza, hepatitis, and others that are used by various end-users such as hospitals and clinics, retail pharmacies, research organizations, and others.

Infectious Disease Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Infectious Disease Therapeutics Market Size and Share 2026?

The infectious disease therapeutics market size has grown strongly in recent years. It will grow from $150.6 billion in 2025 to $160.84 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to high global burden of infectious diseases, widespread use of antibiotics and antivirals, government immunization programs, growth of pharmaceutical manufacturing capacity, increased funding for infectious disease research.

What Is The Infectious Disease Therapeutics Market Growth Forecast?

The infectious disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $200.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to rising antimicrobial resistance rates, increasing frequency of infectious disease outbreaks, expansion of global vaccination coverage, growing demand for novel antiviral therapies, stronger public health preparedness initiatives. Major trends in the forecast period include rising focus on antimicrobial resistance management, increasing development of broad-spectrum therapeutics, growing adoption of combination drug therapies, expansion of rapid-response therapeutics for outbreaks, increased investment in vaccine research and stockpiling.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Infectious Disease Therapeutics Market Segmentation

1) By Type: Drugs, Vaccines

2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases

3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users

Subsegments:

1) By Drugs: Antibiotics, Antivirals, Antifungals, Antiparasitics, Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)

2) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Mrna Vaccines, Dna Vaccines, Toxoid Vaccines

What Is The Driver Of The Infectious Disease Therapeutics Market?

The rising prevalence of infectious diseases is expected to propel the growth of the infectious disease therapeutics market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or prions. The rising infectious diseases are due to several key factors such as climate change and environmental disruption, antimicrobial resistance, weakened immune systems, increasing interactions with animals, and ecological disturbances. Infectious disease therapeutics play a vital role in treating infections, reducing morbidity and mortality, and controlling the spread of communicable diseases within communities and across populations. For instance, in October 2023, according to the National Health Service (NHS) England, a UK-based government department, in 2022/23, hospitals reported 147,285 admissions with a primary diagnosis of urinary tract infection (UTI). Patients aged over 65 represented 56% of these cases, amounting to 82,392 admissions. The 80–84 age group had the highest number of admissions, with 17,280 cases. Therefore, the rising prevalence of infectious diseases drives the infectious disease therapeutics industry.

Key Players In The Global Infectious Disease Therapeutics Market

Major companies operating in the infectious disease therapeutics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, AstraZeneca, Novartis International AG, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceuticals, Moderna Inc., Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioCryst Pharmaceuticals Inc.

Global Infectious Disease Therapeutics Market Trends and Insights

Major companies operating in the infectious disease therapeutics market are focusing on incorporating multispecific antibody platforms such as the multispecific therapeutic antibody reactor (MSTAR) to enhance efficacy, broaden protection, and strengthen responsiveness to emerging viral threats. Multispecific therapeutic antibody reactor (MSTAR) is an advanced multispecific antibody technology that combines several independent binding regions into a single therapeutic molecule, enabling capabilities such as broad viral neutralization, simultaneous targeting of multiple epitopes, and rapid adaptation to new variants. For instance, in September 2023, ModeX Therapeutics Inc, a US-based clinical stage biopharmaceutical company, secured a contract from the Biomedical Advanced Research and Development Authority to advance its multispecific antibody candidates designed for the treatment and prevention of viral infectious diseases including COVID 19 and influenza, featuring broad activity against circulating viral strains, potential compatibility with gene based delivery using mRNA or DNA vectors, and a multi binding site architecture. This multispecific antibody approach improves therapeutic outcomes by shortening development timelines, expanding protective coverage, and reducing the complexity associated with combination biologic treatments.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Infectious Disease Therapeutics Market?

In June 2023, Shionogi & Co., Ltd., a Japan-based pharmaceutical company, acquired Qpex Biopharma Inc. for an undisclosed amount. Through this acquisition, Shionogi aims to expand its infectious disease therapeutics portfolio by integrating Qpex’s advanced pipeline, including xeruborbactam, a first-in-class ß-lactamase inhibitor designed to combat multidrug-resistant bacterial infections. Qpex Biopharma Inc. is a US-based clinical-stage biotechnology company specializing in the development of novel antimicrobial treatments for serious and drug-resistant infectious diseases.

Regional Outlook

North America was the largest region in the infectious disease therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Infectious Disease Therapeutics Market?

The infectious disease therapeutics market consists of sales of antibiotics, antivirals, and immunotherapies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Infectious Disease Therapeutics Market Report 2026?

The infectious disease therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the infectious disease therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Infectious Disease Therapeutics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $160.84 billion
Revenue Forecast In 2035 $200.87 billion
Growth Rate CAGR of 6.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Disease, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, AstraZeneca, Novartis International AG, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceuticals, Moderna Inc., Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioCryst Pharmaceuticals Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Infectious Disease Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Infectious Disease Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Infectious Disease Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Infectious Disease Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Focus On Antimicrobial Resistance Management

4.2.2 Increasing Development Of Broad-Spectrum Therapeutics

4.2.3 Growing Adoption Of Combination Drug Therapies

4.2.4 Expansion Of Rapid-Response Therapeutics For Outbreaks

4.2.5 Increased Investment In Vaccine Research And Stockpiling

5. Infectious Disease Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Retail Pharmacies

5.3 Research Organizations

5.4 Public Health Agencies

5.5 Specialty Infectious Disease Centers

6. Infectious Disease Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Infectious Disease Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Infectious Disease Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Infectious Disease Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Infectious Disease Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Infectious Disease Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Infectious Disease Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Infectious Disease Therapeutics Market Segmentation

9.1. Global Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drugs, Vaccines

9.2. Global Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases

9.3. Global Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users

9.4. Global Infectious Disease Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antibiotics, Antivirals, Antifungals, Antiparasitics, Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)

9.5. Global Infectious Disease Therapeutics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Mrna Vaccines, Dna Vaccines, Toxoid Vaccines

10. Infectious Disease Therapeutics Market Regional And Country Analysis

10.1. Global Infectious Disease Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Infectious Disease Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Infectious Disease Therapeutics Market

11.1. Asia-Pacific Infectious Disease Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Infectious Disease Therapeutics Market

12.1. China Infectious Disease Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Infectious Disease Therapeutics Market

13.1. India Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Infectious Disease Therapeutics Market

14.1. Japan Infectious Disease Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Infectious Disease Therapeutics Market

15.1. Australia Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Infectious Disease Therapeutics Market

16.1. Indonesia Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Infectious Disease Therapeutics Market

17.1. South Korea Infectious Disease Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Infectious Disease Therapeutics Market

18.1. Taiwan Infectious Disease Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Infectious Disease Therapeutics Market

19.1. South East Asia Infectious Disease Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Infectious Disease Therapeutics Market

20.1. Western Europe Infectious Disease Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Infectious Disease Therapeutics Market

21.1. UK Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Infectious Disease Therapeutics Market

22.1. Germany Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Infectious Disease Therapeutics Market

23.1. France Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Infectious Disease Therapeutics Market

24.1. Italy Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Infectious Disease Therapeutics Market

25.1. Spain Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Infectious Disease Therapeutics Market

26.1. Eastern Europe Infectious Disease Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Infectious Disease Therapeutics Market

27.1. Russia Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Infectious Disease Therapeutics Market

28.1. North America Infectious Disease Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Infectious Disease Therapeutics Market

29.1. USA Infectious Disease Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Infectious Disease Therapeutics Market

30.1. Canada Infectious Disease Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Infectious Disease Therapeutics Market

31.1. South America Infectious Disease Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Infectious Disease Therapeutics Market

32.1. Brazil Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Infectious Disease Therapeutics Market

33.1. Middle East Infectious Disease Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Infectious Disease Therapeutics Market

34.1. Africa Infectious Disease Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Infectious Disease Therapeutics Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Infectious Disease Therapeutics Market Regulatory and Investment Landscape

36. Infectious Disease Therapeutics Market Competitive Landscape And Company Profiles

36.1. Infectious Disease Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Infectious Disease Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Infectious Disease Therapeutics Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca Overview, Products and Services, Strategy and Financial Analysis

37. Infectious Disease Therapeutics Market Other Major And Innovative Companies

Novartis International AG, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceuticals, Moderna Inc., Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioCryst Pharmaceuticals Inc.

38. Global Infectious Disease Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Infectious Disease Therapeutics Market

40. Infectious Disease Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Infectious Disease Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Infectious Disease Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Infectious Disease Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Infectious Disease Therapeutics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Infectious Disease Therapeutics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Infectious Disease Therapeutics Market, Supply Chain Analysis
  • Table 4: Global Infectious Disease Therapeutics Market, Major Raw Material Providers
  • Table 5: Global Infectious Disease Therapeutics Market, Major Resource Providers
  • Table 6: Global Infectious Disease Therapeutics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Infectious Disease Therapeutics Market, Major Distributors And Channel Partners
  • Table 8: Global Infectious Disease Therapeutics Market, Key Technologies & Future Trends
  • Table 9: Global Infectious Disease Therapeutics Market, Major Trends
  • Table 10: Global Infectious Disease Therapeutics Market, Major End Users
  • Table 11: Global Infectious Disease Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Infectious Disease Therapeutics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Infectious Disease Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Infectious Disease Therapeutics Market - TAM, US$ Billion, 2025
  • Table 15: Global Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Infectious Disease Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Infectious Disease Therapeutics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Infectious Disease Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Infectious Disease Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Infectious Disease Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Infectious Disease Therapeutics Market - Company Scoring Matrix
  • Table 96: Pfizer Inc. Financial Performance
  • Table 97: F. Hoffmann-La Roche AG Financial Performance
  • Table 98: Merck & Co. Inc. Financial Performance
  • Table 99: Sanofi SA Financial Performance
  • Table 100: AstraZeneca Financial Performance
  • Table 101: Global Infectious Disease Therapeutics Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Infectious Disease Therapeutics Market, Competitive Dashboard
  • Table 103: Global Infectious Disease Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Infectious Disease Therapeutics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 105: Global, Infectious Disease Therapeutics Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030
  • Table 106: Global, Infectious Disease Therapeutics Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Infectious Disease Therapeutics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Infectious Disease Therapeutics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Infectious Disease Therapeutics Market, Supply Chain Analysis
  • Figure 4: Global Infectious Disease Therapeutics Market, Major Raw Material Providers
  • Figure 5: Global Infectious Disease Therapeutics Market, Major Resource Providers
  • Figure 6: Global Infectious Disease Therapeutics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Infectious Disease Therapeutics Market, Major Distributors And Channel Partners
  • Figure 8: Global Infectious Disease Therapeutics Market, Key Technologies & Future Trends
  • Figure 9: Global Infectious Disease Therapeutics Market, Major Trends
  • Figure 10: Global Infectious Disease Therapeutics Market, Major End Users
  • Figure 11: Global Infectious Disease Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Infectious Disease Therapeutics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Infectious Disease Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Infectious Disease Therapeutics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Infectious Disease Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Infectious Disease Therapeutics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Infectious Disease Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Infectious Disease Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Infectious Disease Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Infectious Disease Therapeutics Market - Company Scoring Matrix
  • Figure 96: Pfizer Inc. Financial Performance
  • Figure 97: F. Hoffmann-La Roche AG Financial Performance
  • Figure 98: Merck & Co. Inc. Financial Performance
  • Figure 99: Sanofi SA Financial Performance
  • Figure 100: AstraZeneca Financial Performance
  • Figure 101: Global Infectious Disease Therapeutics Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Infectious Disease Therapeutics Market, Competitive Dashboard
  • Figure 103: Global Infectious Disease Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Infectious Disease Therapeutics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 105: Global, Infectious Disease Therapeutics Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030
  • Figure 106: Global, Infectious Disease Therapeutics Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others...

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global ...

Infectious Disease Therapeutics Market Report 2026 - Global Outlook – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharm...

Hepatitis Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types), By Drug Class (Oral Antivirals, Immune Modulators), By Distribution Channel (Hosp...

Antiviral Combination Therapy Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase ...

Anti-Inflammatory Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics), By Indication (Arthritis, Respiratory Dise...

Antivirals Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes )...

Anti-Infective Drugs Market - By Type (Antibiotics, Antivirals, Antifungals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classifi...

Frequently Asked Questions

The Infectious Disease Therapeutics Market Report 2026 market was valued at $150.6 billion in 2025, increased to $160.84 billion in 2026, and is projected to reach $200.87 billion by 2030. request a sample here

The expected CAGR for the Infectious Disease Therapeutics Market Report 2026 market during the forecast period 2025–2030 is 5.7%. request a sample here

Major growth driver of the market includes: Infectious Diseases On The Upswing A Global Health Concern in the Infectious Disease Therapeutics Market Report 2026 market. For further insights on this market, request a sample here

The infectious disease therapeutics market covered in this report is segmented –
1) By Type: Drugs, Vaccines
2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases
3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users Subsegments:
1) By Drugs: Antibiotics, Antivirals, Antifungals, Antiparasitics, Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)
2) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Mrna Vaccines, Dna Vaccines, Toxoid Vaccines request a sample here

Major trend in this market includes: Innovators Strengthen Infectious Disease Defense Through Multispecific Therapeutic Technologies For further insights on this market, request a sample here.

Major companies operating in the Infectious Disease Therapeutics Market Report 2026 market are Major companies operating in the infectious disease therapeutics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, AstraZeneca, Novartis International AG, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceuticals, Moderna Inc., Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioCryst Pharmaceuticals Inc. request a sample here.

North America was the largest region in the infectious disease therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us